Coronavirus Update: Clover Begins Twin Track Trials With GSK And Dynavax

Plus: Are UK's New Takeover Laws Prompted By AstraZeneca Fears?

Clover enters the clinical trial stage in race to develop a vaccine, while the UK moves to protect a range of key industries from foreign takeover, including vaccines manufacturers. Meanwhile, confirmed cases in Beijing continue to rise.    

Sharma_Alok
UK business minister Alok Sharma: new laws would allow government to block a vaccines company takeover.

China’s Clover Biopharmaceuticals has dosed the first volunteers in its COVID-19 vaccine candidate Phase I trials, and is testing it in conjunction with two separate adjuvants, one from GlaxoSmithKline PLC and the other from Dynavax Technologies Corp.

The start of Clover’s first-in-human studies on 19 June brings the total of major vaccine candidates in clinical trials to...

More from Clinical Trials

More from R&D